These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34795507)

  • 1. Evaluation of Empirical Meropenem Bolus Protocol in
    Suranadi IW; Panji PAS; Budayanti NNS; Senapathi TGA; Susatya AB
    Int J Gen Med; 2021; 14():7861-7867. PubMed ID: 34795507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa is not just in the intensive care unit any more: implications for empirical therapy.
    Eagye KJ; Banevicius MA; Nicolau DP
    Crit Care Med; 2012 Apr; 40(4):1329-32. PubMed ID: 22425824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase-3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP).
    Johnson MG; Bruno C; Castanheira M; Yu B; Huntington JA; Carmelitano P; Rhee EG; De Anda C; Motyl M
    Int J Antimicrob Agents; 2021 Mar; 57(3):106278. PubMed ID: 33434676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing Trend in the Antibiotic Resistance Pattern of Pseudomonas Aeruginosa Isolated from Wound Swabs of Out-Patients and in-Patients of a Tertiary Care Hospital.
    Joseph NM; Devi S; Shashikala P; Kanungo R
    J Clin Diagn Res; 2013 Oct; 7(10):2170-2. PubMed ID: 24298467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic sensitivity pattern of bacterial pathogens in the intensive care unit of Fatmawati Hospital, Indonesia.
    Radji M; Fauziah S; Aribinuko N
    Asian Pac J Trop Biomed; 2011 Jan; 1(1):39-42. PubMed ID: 23569722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa: Evaluation of Pathogen Burden and Drug-Resistance Trends in a Tertiary Care Hospital.
    Saeed M; Rasheed F; Afzal RK; Hussain S; Riaz S; Ahmad A
    J Coll Physicians Surg Pak; 2018 Apr; 28(4):279-283. PubMed ID: 29615167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.
    Hakki M; Humphries RM; Hemarajata P; Tallman GB; Shields RK; Mettus RT; Doi Y; Lewis JS
    Clin Infect Dis; 2019 May; 68(12):2045-2052. PubMed ID: 30256922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic impact of meropenem resistance in Pseudomonas aeruginosa-infected patients.
    Judd WR; Ratliff PD; Hickson RP; Stephens DM; Kennedy CA
    Am J Infect Control; 2016 Nov; 44(11):1275-1279. PubMed ID: 27320901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial Susceptibility Trends and Risk Factors for Antimicrobial Resistance in
    Kang JS; Moon C; Mun SJ; Lee JE; Lee SO; Lee S; Lee SH
    J Korean Med Sci; 2021 Nov; 36(43):e273. PubMed ID: 34751008
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Goodlet KJ; Nicolau DP; Nailor MD
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
    Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
    PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenem-Nonsusceptible
    Asempa TE; Nicolau DP; Kuti JL
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31118271
    [No Abstract]   [Full Text] [Related]  

  • 13. A Combination Antibiogram Evaluation for
    Puzniak L; DePestel DD; Srinivasan A; Ye G; Murray J; Merchant S; DeRyke CA; Gupta V
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917987
    [No Abstract]   [Full Text] [Related]  

  • 14. [Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].
    Acuner IC; Bayramoğlu G; Birinci A; Cekiç Cihan C; Bek Y; Durupınar B
    Mikrobiyol Bul; 2011 Jul; 45(3):411-21. PubMed ID: 21935774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality.
    Vitkauskienė A; Skrodenienė E; Dambrauskienė A; Macas A; Sakalauskas R
    Medicina (Kaunas); 2010; 46(7):490-5. PubMed ID: 20966623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.
    Mekonnen H; Seid A; Molla Fenta G; Gebrecherkos T
    PLoS One; 2021; 16(11):e0257272. PubMed ID: 34780494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
    McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and resistance patterns of Pseudomonas aeruginosa in a tertiary care hospital in Kosovo.
    Lila G; Mulliqi-Osmani G; Bajrami R; Kurti A; Azizi E; Raka L
    Infez Med; 2017 Mar; 25(1):21-26. PubMed ID: 28353451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distributed lags time series analysis versus linear correlation analysis (Pearson's r) in identifying the relationship between antipseudomonal antibiotic consumption and the susceptibility of Pseudomonas aeruginosa isolates in a single Intensive Care Unit of a tertiary hospital.
    Erdeljić V; Francetić I; Bošnjak Z; Budimir A; Kalenić S; Bielen L; Makar-Aušperger K; Likić R
    Int J Antimicrob Agents; 2011 May; 37(5):467-71. PubMed ID: 21277747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.